Rewa Ivf Centre Private Limited
Develops and sells real estate properties and infrastructures.
2021 | Rewa, Madhya Pradesh (India) | Active
Rewa Ivf Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.35 M
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 3.75%
About Rewa Ivf Centre
Rewa Ivf Centre Private Limited (RICPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 November 2021 (Three years and three months 7 days old ). Its registered office is in Rewa, Madhya Pradesh, India.
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.35 M, as per Ministry of Corporate Affairs (MCA) records.
Shivendra Shukla, Rita Singh, Anju Shukla, and Two other members serve as directors at the Company.
Company Details
- Location
Rewa, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85300MP2021PTC058510
- Company No.
058510
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Real Estate and Construction
Who are the key members and board of directors at Rewa Ivf Centre?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivendra Shukla  | Director | 22-Nov-2021 | Current |
| Rita Singh | Director | 22-Nov-2021 | Current |
| Anju Shukla | Director | 22-Nov-2021 | Current |
| Nidhi Dwivedi | Director | 22-Nov-2021 | Current |
| Saharsh Shukla | Director | 22-Nov-2021 | Current |
Financial Performance of Rewa Ivf Centre.
Rewa Ivf Centre Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rewa Ivf Centre?
In 2023, Rewa Ivf Centre had a public holding of 28.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Rewa Hospital & Research Center Private Limited
Shivendra Shukla, Rita Singh and 3 more are mutual person
- Hospray Surgitech Private Limited
Rita Singh, Anju Shukla and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rewa Ivf Centre?
Rewa Ivf Centre has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rewa Ivf Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rewa Ivf Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.